28.02.2013 Views

Alto Palermo S.A. (APSA)

Alto Palermo S.A. (APSA)

Alto Palermo S.A. (APSA)

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Alto</strong> <strong>Palermo</strong> S.A. (<strong>APSA</strong>)<br />

Notes to the Consolidated Financial Statements (continued)<br />

(In Argentine Pesos, except as otherwise indicated)<br />

19. Differences between Argentine GAAP and US GAAP (continued)<br />

II. Additional disclosure requirements<br />

d) Disclosure about fair value of financial instruments<br />

Under Argentine GAAP, there are no specific rules regarding disclosure of fair value of financial instruments.<br />

Under US GAAP, SFAS No. 105 requires reporting entities to disclose certain information about financial<br />

instruments with off-balance sheet risk of accounting loss. SFAS No. 107, "Disclosures About Fair Value of Financial<br />

Instruments", requires disclosure of fair value information about financial instruments whether or not recognized in the<br />

balance sheet, for which it is practicable to estimate fair value. Financial instruments include such items as cash and cash<br />

equivalents and accounts receivable and other instruments. SFAS No. 107 excludes from its disclosure requirements lease<br />

contracts and various significant assets and liabilities that are not considered to be financial instruments. SFAS No. 119<br />

requires reporting entities to disclose certain information for derivative financial instruments. SFAS No. 133 superseded<br />

SFAS No. 105 and SFAS No. 119 and amended SFAS No. 107 to include in SFAS No. 107 the disclosure requirements of<br />

credit risk concentrations from SFAS No. 105. See Note 19.II.e) for details of concentration of credit risk.<br />

Fair value estimates are made as of a specific point in time based on the characteristics of the financial instruments<br />

and the relevant market information. Where available, quoted market prices are used. In other cases, fair values are based on<br />

estimates using other valuation techniques, such as discounting estimated future cash flows using a rate commensurate with<br />

the risks involved or other acceptable methods. These techniques involve uncertainties and are significantly affected by the<br />

assumptions used and the judgments made regarding risk characteristics of various financial instruments, prepayments,<br />

discount rates, estimates of future cash flows, future expected loss experience, and other factors. Changes in assumptions<br />

could significantly affect these estimates. Derived fair value estimates cannot be substantiated by comparison to independent<br />

markets and, in many cases, could not be realized in an immediate sale of the instrument. Also, because of differences in<br />

methodologies and assumptions used to estimate fair value, the Company's fair values should not be compared to those of<br />

other companies.<br />

Under this statement, fair value estimates are based on existing financial instruments without attempting to estimate<br />

the value of anticipated future business and the value of assets and liabilities that are not considered financial instruments.<br />

Accordingly, the aggregate fair value amount presented does not represent the underlying value of the Company. For<br />

certain assets and liabilities, the information required under this statement is supplemental with additional information<br />

relevant to an understanding of the fair value.<br />

The methods and assumptions used to estimate the fair values of each class of financial instruments as of June 30,<br />

2007 and 2006 are as follows:<br />

F-64

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!